Cita APA (7a ed.)

A, A., N, B., R, C., T, W., G, M., M, H., . . . JJ, C. (2017). Long-term safety and efficacy of biosimilar infliximab among patients with inflammatory arthritis switched from reference product. Dove Medical Press.

Cita Chicago Style (17a ed.)

A, Abdalla, Byrne N, Conway R, Walsh T, Mannion G, Hanly M, O'Sullivan M, Curran AM, y Carey JJ. Long-term Safety and Efficacy of Biosimilar Infliximab Among Patients with Inflammatory Arthritis Switched from Reference Product. Dove Medical Press, 2017.

Cita MLA (8a ed.)

A, Abdalla, et al. Long-term Safety and Efficacy of Biosimilar Infliximab Among Patients with Inflammatory Arthritis Switched from Reference Product. Dove Medical Press, 2017.